Supported by the National Science and Technology Major Project(2011ZX09102-010-04)
Objective To genetically correct a disease-causing point mutation in human induced pluripotent stem cells (iPSCs) derived from a hemophilia B patient. Methods First, the disease-causing mutation was detected by ...